Ask AI
ProCE Banner Activity

Optimierung der Behandlung des Mantelzelllymphoms: Fallbasierte Empfehlungen von EU-Experten

PDF

Dieses Modul stellt Sichtweisen von Experten aus der EU zum aktuellen Behandlungsalgorithmus, Richtlinien und evidenzbasierten Ansätzen für die optimale Integration verfügbarer Therapien in die Behandlung von Patienten mit Mantelzelllymphom (MCL) vor. Dabei werden das Alter der Patienten, ihr Allgemeinzustand, das Vorliegen von Hochrisiko-Merkmalen, bestehende Begleiterkrankungen und die Begleitmedikation sorgfältig berücksichtigt.

Released: June 16, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca

Target Audience

This activity is intended for global hematology/oncology physician specialists and other healthcare professionals providing care for patients with mantle cell lymphoma. 

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Plan BTK inhibitor-based combination strategies for patients with treatment-naïve MCL, considering new indications, expert recommendations, and available efficacy and safety evidence

  • Select chemotherapy-free treatment strategies for appropriate patients with MCL
    Manage treatment-related adverse events associated with targeted therapies alone or in combination to extend duration on treatment and improve clinical outcomes

  • Manage treatment-related adverse events associated with targeted therapies alone or in combination to extend duration on treatment and improve clinical outcomes